These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21459941)

  • 1. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
    Branco JC; Cherin P; Montagne A; Bouroubi A;
    J Rheumatol; 2011 Jul; 38(7):1403-12. PubMed ID: 21459941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
    Branco JC; Zachrisson O; Perrot S; Mainguy Y;
    J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
    Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
    J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milnacipran: in fibromyalgia.
    Chwieduk CM; McCormack PL
    Drugs; 2010; 70(1):99-108. PubMed ID: 20030428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
    Arnold LM; Bateman L; Palmer RH; Lin Y
    Pediatr Rheumatol Online J; 2015 Jun; 13():27. PubMed ID: 26112278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
    Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.
    Ahmed M; Aamir R; Jishi Z; Scharf MB
    J Clin Sleep Med; 2016 Jan; 12(1):79-86. PubMed ID: 26414990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
    Staud R; Lucas YE; Price DD; Robinson ME
    J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milnacipran for neuropathic pain and fibromyalgia in adults.
    Derry S; Gill D; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD008244. PubMed ID: 22419330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of milnacipran in patients with fibromyalgia.
    Gendreau RM; Thorn MD; Gendreau JF; Kranzler JD; Ribeiro S; Gracely RH; Williams DA; Mease PJ; McLean SA; Clauw DJ
    J Rheumatol; 2005 Oct; 32(10):1975-85. PubMed ID: 16206355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milnacipran for pain in fibromyalgia in adults.
    Cording M; Derry S; Phillips T; Moore RA; Wiffen PJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008244. PubMed ID: 26482422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
    J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
    Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
    J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milnacipran for treatment of fibromyalgia.
    Kyle JA; Dugan BD; Testerman KK
    Ann Pharmacother; 2010 Sep; 44(9):1422-9. PubMed ID: 20716692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
    Arnold LM; Palmer RH; Ma Y
    Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study.
    Trugman JM; Palmer RH; Ma Y
    Curr Med Res Opin; 2014 Apr; 30(4):589-97. PubMed ID: 24188161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.